MPM Capital L.P.

MPM Capital L.P.

  • 111 Huntington Ave Fl 31
  • Boston, Massachusetts
  • 2199

Website Links

Description

BOSTON, Feb. 17, 2014 /PRNewswire/ — MPM Capital and Atlas Venture announced today that portfolio company CoStim Pharmaceuticals, Inc. (“CoStim”) has been acquired by Novartis for an undisclosed amount. CoStim, founded in 2012 by MPM Managing Director Luke Evnin together with MPM Managing Director-Operations Robert Millman, is an emerging immuno-oncology company developing monoclonal antibody drugs that enable a patient’s own immune system to better fight cancer.

Amphivena Therapeutics Inc., Wilmington, Delaware, U.S.A., is a subsidiary of Affimed and was founded in December 2012. Amphivena will partner with Affimed to discover and develop a bispecific TandAb in a hematologic indication.

Sideris Pharmaceuticals Inc. is a privately held biopharmaceutical company that is focused on development of therapeutics for the treatment of transfusion-related iron overload. The company’s operations include facilities in Boston, MA, and in Gainesville, FL. For additional information please visit our website at www.siderispharmaceuticals.com.

Bristol-Myers Squibb Company (NYSE: BMY) and iPierian, Inc. announced today that Bristol-Myers Squibb has acquired iPierian, a privately held biotechnology company focused on the discovery and development of new treatments for Tauopathies, a class of neurodegenerative diseases associated with the pathological aggregation of Tau protein in the human brain.

Astellas Pharma Inc., located in Tokyo, Japan, is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceuticals. Astellas has approximately 17,000 employees worldwide. The organization is committed to becoming a global category leader in Urology, Immunology (including Transplantation) and Infectious diseases, Oncology, Neuroscience and Diabetes Mellitus (DM) Complications and Kidney diseases. For more information on Astellas Pharma Inc., please visit the company website at www.astellas.com/en.

Fact sheet

Number of employees
15-29

Company contacts

  • Luke Evnin
  • Partner

Products & services

Similar companies nearby